S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Cintas: A Quality Buy and Hold Forever Stock at Any Price
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
3 Household Names With RSIs That Scream Oversold
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
The Odds Are High Costco Will Declare a Special Dividend Soon 
Stock market today: Global shares mostly fall over China worries
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
How You Can Reverse Engineer Michael Burry's Latest Buy
This Little Known Automaker May Save Your Life and Your Portfolio
S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Cintas: A Quality Buy and Hold Forever Stock at Any Price
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
3 Household Names With RSIs That Scream Oversold
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
The Odds Are High Costco Will Declare a Special Dividend Soon 
Stock market today: Global shares mostly fall over China worries
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
How You Can Reverse Engineer Michael Burry's Latest Buy
This Little Known Automaker May Save Your Life and Your Portfolio
S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Cintas: A Quality Buy and Hold Forever Stock at Any Price
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
3 Household Names With RSIs That Scream Oversold
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
The Odds Are High Costco Will Declare a Special Dividend Soon 
Stock market today: Global shares mostly fall over China worries
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
How You Can Reverse Engineer Michael Burry's Latest Buy
This Little Known Automaker May Save Your Life and Your Portfolio
S&P 500   4,274.51
DOW   33,550.27
QQQ   355.04
Cintas: A Quality Buy and Hold Forever Stock at Any Price
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Pain for Gain: 2 Stocks Whose CEOs Left Without a Clue
3 Household Names With RSIs That Scream Oversold
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
The Odds Are High Costco Will Declare a Special Dividend Soon 
Stock market today: Global shares mostly fall over China worries
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
How You Can Reverse Engineer Michael Burry's Latest Buy
This Little Known Automaker May Save Your Life and Your Portfolio
NYSE:STVN

Stevanato Group (STVN) Competitors

€29.37
+2.30 (+8.50%)
(As of 09/27/2023 09:03 PM ET)
Compare
Today's Range
€26.66
€29.62
50-Day Range
€26.91
€35.49
52-Week Range
€13.71
€36.30
Volume
391,100 shs
Average Volume
295,332 shs
Market Capitalization
$8.68 billion
P/E Ratio
50.64
Dividend Yield
N/A
Price Target
N/A

STVN vs. SWAV, TFX, PEN, INSP, GMED, PODD, HAE, MMSI, NARI, and GKOS

Should you be buying Stevanato Group stock or one of its competitors? The main competitors of Stevanato Group include Shockwave Medical (SWAV), Teleflex (TFX), Penumbra (PEN), Inspire Medical Systems (INSP), Globus Medical (GMED), Insulet (PODD), Haemonetics (HAE), Merit Medical Systems (MMSI), Inari Medical (NARI), and Glaukos (GKOS). These companies are all part of the "surgical & medical instruments" industry.

Stevanato Group vs.

Shockwave Medical (NASDAQ:SWAV) and Stevanato Group (NYSE:STVN) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk, community ranking and dividends.

Shockwave Medical received 100 more outperform votes than Stevanato Group when rated by MarketBeat users. However, 66.67% of users gave Stevanato Group an outperform vote while only 56.62% of users gave Shockwave Medical an outperform vote.

CompanyUnderperformOutperform
Shockwave MedicalOutperform Votes
124
56.62%
Underperform Votes
95
43.38%
Stevanato GroupOutperform Votes
24
66.67%
Underperform Votes
12
33.33%

Shockwave Medical has a net margin of 39.56% compared to Shockwave Medical's net margin of 14.24%. Stevanato Group's return on equity of 47.48% beat Shockwave Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Shockwave Medical39.56% 47.48% 36.24%
Stevanato Group 14.24%15.12%8.93%

Shockwave Medical currently has a consensus target price of $292.29, indicating a potential upside of 46.41%. Given Stevanato Group's stronger consensus rating and higher possible upside, equities analysts clearly believe Shockwave Medical is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Shockwave Medical
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86
Stevanato Group
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

In the previous week, Shockwave Medical had 10 more articles in the media than Stevanato Group. MarketBeat recorded 17 mentions for Shockwave Medical and 7 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 0.71 beat Shockwave Medical's score of 0.59 indicating that Shockwave Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Shockwave Medical
8 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Stevanato Group
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

87.4% of Shockwave Medical shares are held by institutional investors. Comparatively, 10.9% of Stevanato Group shares are held by institutional investors. 3.4% of Shockwave Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Shockwave Medical has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500.

Shockwave Medical has higher earnings, but lower revenue than Stevanato Group. Shockwave Medical is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Shockwave Medical$489.73M14.98$216M$6.4231.10
Stevanato Group$1.04B8.37$150.51M$0.5850.64

Summary

Shockwave Medical beats Stevanato Group on 15 of the 18 factors compared between the two stocks.


Get Stevanato Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for STVN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STVN vs. The Competition

MetricStevanato GroupSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$8.68B$3.54B$4.38B$15.10B
Dividend YieldN/A3.48%2.50%3.70%
P/E Ratio50.6455.52155.1422.42
Price / Sales8.3719.232,951.088.68
Price / Cash35.5155.6592.5017.08
Price / Book8.273.633.746.62
Net Income$150.51M$63.85M$122.36M$901.90M
7 Day Performance7.11%-1.51%-0.72%-1.20%
1 Month Performance-9.58%-6.53%-4.05%-4.47%
1 Year Performance62.80%-16.57%8.37%6.87%

Stevanato Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SWAV
Shockwave Medical
2.8718 of 5 stars
$196.15
+0.9%
$292.29
+49.0%
-23.5%$7.21B$489.73M30.551,001Insider Selling
Short Interest ↑
Analyst Revision
TFX
Teleflex
2.7633 of 5 stars
$199.94
-1.7%
$268.92
+34.5%
-2.7%$9.40B$2.90B25.6715,500
PEN
Penumbra
2.646 of 5 stars
$245.61
-0.6%
$324.38
+32.1%
+30.7%$9.44B$847.13M331.913,900
INSP
Inspire Medical Systems
2.8419 of 5 stars
$187.31
+1.2%
$345.08
+84.2%
+10.5%$5.50B$407.86M-130.08755Short Interest ↑
Positive News
GMED
Globus Medical
3.0642 of 5 stars
$49.50
-1.5%
$68.22
+37.8%
-14.0%$4.97B$759.12M24.632,600Short Interest ↓
PODD
Insulet
3.1499 of 5 stars
$159.29
+3.0%
$281.93
+77.0%
-29.9%$11.12B$1.31B178.982,600Short Interest ↓
Gap Up
HAE
Haemonetics
2.3666 of 5 stars
$88.24
-3.7%
$103.67
+17.5%
+21.9%$4.65B$1.22B33.303,034Positive News
MMSI
Merit Medical Systems
2.8843 of 5 stars
$67.33
-1.5%
$87.83
+30.5%
+23.5%$3.88B$1.15B43.166,846Analyst Report
NARI
Inari Medical
2.5628 of 5 stars
$64.96
+0.4%
$85.22
+31.2%
-4.4%$3.73B$383.47M-216.531,100
GKOS
Glaukos
1.7657 of 5 stars
$75.43
-1.2%
$77.56
+2.8%
+53.3%$3.67B$282.86M-28.57783Analyst Report
News Coverage

Related Companies and Tools

This page (NYSE:STVN) was last updated on 9/28/2023 by MarketBeat.com Staff

My Account -